A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, while helping some avoid further tests and treatments, including chemotherapy.

Using FoundationOne Liquid, a novel liquid biopsy test providing targeted gene and microsatellite instability-high results, researchers sought to examine whether specific biomarkers contribute to TNBC ...

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing ...

Biopsies are a necessary burden for people with cancer. Taking a small sample of tissue and sending it through genetic and molecular analysis can help doctors not just diagnose cancer, but also learn ...

A new liquid biopsy blood test could help detect cases of human papillomavirus (HPV)-associated head and neck cancers with significantly higher accuracy than currently used methods, including before ...

IRVINE, Calif.--(BUSINESS WIRE)--Genomic Testing Cooperative, LCA (GTC) announced that it will be presenting at the American Society of Clinical Oncology (ASCO) 2022 annual meeting data showcasing its ...

New Bridge Capture method offers advances for clinical testing, disease monitoring and treatment selection.

A company developing liquid biopsy technology for the early detection of cancers has new data that it is presenting Saturday at a major cancer conference. Menlo Park, California-based Grail said it ...